Simon Chiu

Title: Simon Chiu: Innovator in Neurodegenerative Disorder Treatments

Introduction

Simon Chiu is a notable inventor based in London, Canada. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patent developments. His work focuses on the therapeutic potential of curcumin and its derivatives in treating various neurological conditions.

Latest Patents

Simon Chiu holds a patent for "Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders." This patent includes liposomal formulations and polymer conjugates of curcumin, curcumin analogs, and derivatives for parenteral administration. The formulations are effective in treating progressive supranuclear palsy, Alzheimer's disease, Parkinson's disease, Tauopathies, and stress disorders, including Post Traumatic Stress Disorder. Curcumin is known to cross the blood-brain barrier, localize in the hippocampus and striata, prevent stress-induced neuronal cell damage, and stimulate neurogenesis and remediation of damaged neural circuits.

Career Highlights

Simon Chiu is associated with Signpath Pharma, Inc., where he continues to advance his research in neurodegenerative disorders. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from debilitating neurological conditions.

Collaborations

Simon collaborates with Lawrence Helson, a fellow researcher, to further explore the applications of curcumin in medical treatments. Their combined expertise enhances the potential for innovative solutions in the field of neurodegenerative disorders.

Conclusion

Simon Chiu's contributions to the treatment of neurodegenerative disorders through his patented formulations of curcumin highlight his role as a leading inventor in this critical area of research. His work promises to pave the way for new therapeutic strategies that could significantly benefit patients worldwide.